36 related articles for article (PubMed ID: 30503067)
1. Incidence and profile of skin cancers in patients following ultraviolet phototherapy without psoralens: A retrospective cohort study.
Wang E; Ahad T; Liu YA; Lee TK; Lui H; Crawford RI; Kalia S
J Am Acad Dermatol; 2024 Apr; 90(4):759-766. PubMed ID: 38070541
[TBL] [Abstract][Full Text] [Related]
2. Skin Cancer Risk of Narrow-Band UV-B (TL-01) Phototherapy: A Multi-Center Registry Study with 4,815 Patients.
Åkerla P; Pukkala E; Helminen M; Korhonen N; Karppinen T
Acta Derm Venereol; 2024 Apr; 104():adv39927. PubMed ID: 38629891
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical Investigation of Psoralen Binding to Double Stranded DNA through Electroanalytical and Cheminformatic Approaches.
Thomaz DV; de Oliveira MG; Rodrigues ESB; da Silva VB; Dos Santos PA
Pharmaceuticals (Basel); 2020 May; 13(6):. PubMed ID: 32481669
[TBL] [Abstract][Full Text] [Related]
4. PUVA and skin cancer. A historical cohort study on 492 patients.
Chuang TY; Heinrich LA; Schultz MD; Reizner GT; Kumm RC; Cripps DJ
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):173-7. PubMed ID: 1552048
[TBL] [Abstract][Full Text] [Related]
5. 'High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer.
Bruynzeel I; Bergman W; Hartevelt HM; Kenter CC; Van de Velde EA; Schothorst AA; Suurmond D
Br J Dermatol; 1991 Jan; 124(1):49-55. PubMed ID: 1993145
[TBL] [Abstract][Full Text] [Related]
6. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study.
Nijsten TE; Stern RS
J Invest Dermatol; 2003 Aug; 121(2):252-8. PubMed ID: 12880415
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
[TBL] [Abstract][Full Text] [Related]
8. Incidence of non-melanoma skin cancer in patients treated with psoralen and ultraviolet A therapy.
Ortiz Salvador JM; Pérez-Ferriols A; Alegre de Miquel V; Saneleuterio Temporal M; Vilata Corell JJ
Med Clin (Barc); 2019 Jun; 152(12):488-492. PubMed ID: 30503067
[TBL] [Abstract][Full Text] [Related]
9. [Puva therapy and carcinogenesis].
Thomas P; Pannequin C
Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842
[No Abstract] [Full Text] [Related]
10. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
11. Skin Cancer Risk (Nonmelanoma Skin Cancers/Melanoma) in Vitiligo Patients.
Rodrigues M
Dermatol Clin; 2017 Apr; 35(2):129-134. PubMed ID: 28317522
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
